Skip to main content
. 2020 Feb 17;19:1533033819886896. doi: 10.1177/1533033819886896

Figure 1.

Figure 1.

Schematic diagram showing the principle of the combined targeting of angiogenesis with ziv-aflibercept and sorafenib.